## MLM: Martin Marietta Materials, Inc. - XLB: Basic Materials

### Executive Summary

No thesis match: MRS_20 1.1% below STRENGTH zone (4.0-10.0%); PEG 3.58 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($605.29)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 2
- **Sentiment:** Bullish (Bullish: 0, Bearish: 0)

**1. Martin Marietta extends and modifies key credit facility**
- Source: The Globe and Mail | 20251221T020827 | Somewhat-Bullish | Relevance: 100%
- Martin Marietta Materials (MLM) has extended and modified a key credit facility with its lenders and JPMorgan Chase Bank, amending its existing financing arrangements. This move, announced on December 19, 2025, aims to support the company's capital structure and liquidity. Analysts currently rate MLM as a Buy with a $730.00 price target, and TipRanks' AI Analyst, Spark, also rates it "Outperform" due to its strong financial position despite potential overvaluation risks.

**2. Pervious Concrete Pavers Market Is Going to Boom |• BASF SE • CEMEX S.A.B. de C.V.**
- Source: openPR.com | 20251223T011015 | Somewhat-Bullish | Relevance: 70%
- Worldwide Market Reports has released a new research study on the "Pervious Concrete Pavers Market," predicting substantial growth in the coming years. The comprehensive report analyzes market dynamics, drivers, restraints, and opportunities across various segments and regions. Key players like BASF SE, CEMEX S.A.B. de C.V., and Holcim Group are highlighted in this study that covers both historical performance and future growth forecasts.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 3, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-22 | Morgan Stanley | $690 | $660 | +5% |
| 2025-12-15 | Jefferies | $730 | $725 | +1% |
| 2025-12-01 | Morgan Stanley | $660 | $610 | +8% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-22 | Morgan Stanley | main | Overweight |
| 2025-12-15 | Jefferies | main | Buy |
| 2025-12-01 | Morgan Stanley | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 3 ($0.12M) |
| Sells | 7 ($0.61M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 54.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 12.3% (+1.3%)
- JPMORGAN CHASE & CO: 9.7% (+98.6%)
- Blackrock Inc.: 6.9% (-1.8%)
- FMR, LLC: 4.8% (-4.3%)
- State Street Corpora: 4.6% (-1.0%)

### Key Risks

1. Valuation stretched: PEG 3.6x requires aggressive growth execution.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Analyst target momentum: 3 raises (avg +4%) could attract flows.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 3.58 signals overvaluation risk, limited margin of safety. Quality metrics strong (margin 17%). Balance sheet: strong liquidity (3.0x). Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $38.1B |
| Beta | 1.16 |
| 52W Range | $441.95 - $665.18 |
| Short Interest | 3.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.58 |
| Forward P/E | 28.5 |
| Current P/E | 33.8 |
| YoY Growth | 18.7% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 2.3% to 1.1% (-1.3% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 2.9pp (needs >4.0% for momentum thesis). MRS_5 (-0.7%) diverging from MRS_20 - short-term weakness emerging. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (1.23), confirming momentum. RSI neutral at 57. Elevated volume (1.4x 20MA), institutional activity likely. OFD pattern: -MTN (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 1.08% (CS: 59) | Neutral |
| RSI_14 | 57.1 | Neutral |
| MACD Histogram | 1.23 | Bullish |
| vs SMA20 | 1.017x | Above |
| vs SMA50 | 1.022x | Above |
| vs SMA200 | 1.104x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $632.53
- **Stop Loss:** $605.29 (4.3% risk)
- **Target:** $659.77 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 33
- **Position Value:** $20,873.49
- **Portfolio %:** 20.87%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with improving risk appetite. VIX decline to 52-week lows and moderate breadth recovery suggest calming conditions, though narrow participation indicates selectivity remains key. Positive earnings momentum and AI adoption themes provide fundamental support for quality growth names.*

### Earnings

**Next:** 2026-02-11 (Est: $4.98)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $6.68 | $6.85 | +2.5% |
| 2025Q2 | $5.26 | $5.43 | +3.2% |
| 2025Q1 | $1.88 | $1.90 | +1.1% |
| 2024Q4 | $4.56 | $4.81 | +5.5% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_20*